Philip Morris' premium valuations are justified by ZYN's FDA approval, smoke-free growth, and market dominance. See why PM ...

In recent years, the tobacco industry has witnessed a significant shift towards alternative products that aim to reduce the ...

The launch follows the 10-Year Anniversary of IQOS Dubai, United Arab Emirates - March 3, 2025 - Philip Morris Middle East ...

There are three devices in the IQOS Iluma i series in Japan, one more than will initially launch Korea. The line provides a “better alternative for adult smokers who cannot quit,” said Yun.

Philip Morris continues to see solid growth led by Zyn. It has a big opportunity in a few years with its IQOS product in the U.S. The stock is attractively valued and still has a nice dividend yield.